Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.

Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q35125031

about

The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis Chemotherapy targeting cancer stem cells Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.2-Deoxyglucose Reverses the Promoting Effect of Insulin on Colorectal Cancer Cells In Vitro Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis.Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome.Prognostic value of glycated hemoglobin in colorectal cancer.Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats.Expanding the therapeutic spectrum of metformin: from diabetes to cancer.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer.Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.Increased 30-day mortality in patients with diabetes undergoing surgery for colorectal cancer.Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population.The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma.Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients.Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.Metformin and blood cancers

P2860

Q27026813-8204146A-C17C-4161-B222-69560AA17756 Q28074225-5C1AB366-AF81-428C-BA04-D7EA87BFFE06 Q28085377-5B09485D-5206-4A35-B6D2-2B3F113BBD90 Q30234587-03D49411-3111-4C46-919D-7B89DEAE030D Q30239808-61146C95-CCC6-4622-8885-4DD304FD0E5F Q33688699-1242D941-FC0C-4D44-84F7-8BC08AD6AECB Q34483533-B4B3E50A-8016-4A30-A542-C2F5EBA565CB Q34483541-B47698C7-5B2C-4A84-B0B8-92BA6E89D833 Q35944860-CD108CAB-DBFD-49CA-8EB5-46EAC396C31C Q36182935-F5879B53-68BA-4874-A2E5-ACE08FC8330E Q36300318-6B10DAF4-AE51-4D81-B254-A6E600791FD9 Q36356897-1857F5A9-C312-4AA4-91BA-5C300E6B9505 Q36853961-E727BFB7-F062-40FD-8A58-B113C9928AA2 Q37483467-42B6C38F-718D-48D4-A5BF-7B9B02DA1559 Q37606635-B4A2EEC7-15A9-48BC-973D-78F0C4DCC343 Q37720435-051CF91F-F489-457F-BC96-EDBE39BC7D4C Q38558943-BB336A84-D4A4-4062-9E50-BD651329B2CE Q38728567-13EC78BD-012F-4F97-AD1E-0D343599457F Q39040854-F8479EBF-2694-48AB-A389-682B2E9D3AFF Q39519100-042CF0F5-E924-45F3-915C-5318B4C311CE Q39714372-6A1E305F-92C9-42AA-B367-757EBA33DFBA Q40161015-FF127024-4E80-48CF-989F-5492581C4C45 Q40431485-E92A62D9-46C8-4D57-BDCF-5570959DB8A4 Q42124995-F10EA3BC-1F61-4E26-9D3F-54F45A857607 Q42371618-8DF8A1B2-064E-4EED-B8E6-15A64F04B41E Q42382907-36C0131E-C79C-479C-B4BA-C227A0B19275 Q47133179-157D970D-A037-41B3-B084-2E31081D4F4A Q48225072-3689CB7B-299D-498B-9094-CECAE4C63ACE Q48238900-B50E61FD-AF02-4148-979D-1E4C432F4CDC Q49873927-A0F6AE13-139A-42C5-9BB3-1C00E7947A72 Q53260164-89DBF5B9-8088-4068-895A-ED52365171CB Q55030699-2C421DF7-891D-4B44-BD8C-C17278027C22 Q58699189-1874664B-1DE6-41FF-8BBC-F94915AF3E76

P2860

Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q35125031

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Survival benefits of metformin ...... atic review and meta-analysis.

@ast

Survival benefits of metformin ...... atic review and meta-analysis.

@en

type

label

Survival benefits of metformin ...... atic review and meta-analysis.

@ast

Survival benefits of metformin ...... atic review and meta-analysis.

@en

prefLabel

Survival benefits of metformin ...... atic review and meta-analysis.

@ast

Survival benefits of metformin ...... atic review and meta-analysis.

@en

P1433

Q35125031-4E434B2C-6584-4776-9A19-73DCA365ACB7

P1476

Q35125031-29DA73C6-352B-41BE-B4BC-CF8DB59E5520

P2093

Q35125031-0F67EF51-D871-47FE-ACBA-05454745E54F

Q35125031-1127143A-7AB6-421E-85A9-13694980C94E

Q35125031-4E8D1D09-F0F4-4BCB-B5DD-DD689AFF4AA4

Q35125031-8D332C46-9CDD-4954-8D03-2F7ECF3C255B

Q35125031-B2E19C4F-EC00-4333-9816-BA01038929E4

Q35125031-B8E8311E-1A9E-4252-9669-AE7B55AE1514

Q35125031-BBE99EB9-846D-4A8C-B0C3-46F4C40EB6A3

Q35125031-C51C0E01-9CFC-4AD1-A8D1-CECB697331D1

P275

Q35125031-42360986-45E8-4B29-BA1A-616C05779191

P2860

Q35125031-0AB7D26F-57AA-4962-B87D-824D01A23D07

Q35125031-169C569C-BF68-4A0C-BCD0-2C29B46178C3

Q35125031-178D4B89-7F8D-4938-87EA-0E69DD56FE74

Q35125031-17B855C3-B246-4E6A-915B-D645CB0B6D41

Q35125031-1BB91540-5F49-4314-BEC4-60FFA65CDD30

Q35125031-20B96857-0D93-4728-9D16-D9E96352C23E

Q35125031-253486A8-AF7D-4D5F-9B70-0C5DF1CE1385

Q35125031-490BDBD6-FA3C-4BBB-B0B3-3017A4EBD179

Q35125031-4BC0E8B4-F6F6-441E-8E2F-FE4F316379DD

Q35125031-76FAF1E6-A156-40EE-8BF4-2183D230018B

P304

Q35125031-2D5ABB96-2776-45A0-A71F-29D582917162

P31

Q35125031-49f995cd-8b3e-4254-a178-8c3b509f0413

Q35125031-CD951FE7-6671-4BDC-8DDA-FE34249401EE

Q35125031-F5BED67F-73F4-4828-93B8-57DFC6448703

P356

Q35125031-8D782B92-F084-4027-A7EB-BC0F822716B4

P407

Q35125031-A4C945EA-07F5-4613-B50E-5D5AB32F3C9D

P433

Q35125031-D38020E9-898D-4123-9D42-530FD335425C

P478

Q35125031-4276E923-0A35-47A6-BDD4-46EB52146898

P5008

Q35125031-98464011-62A7-4FFA-8BB7-CB76ACA1DF50

P577

Q35125031-A53B0F68-ADE0-46E4-9ED0-73F0A61FE531

P5875

Q35125031-73BC928D-3AD6-4825-A0C6-955B88A69259

P698

Q35125031-B0280830-6CFA-41E1-9F0E-49AB22ED3429

P921

Q35125031-252C636D-D6F1-4ABC-8424-53FDF1646C7D

Q35125031-2C3AB49E-3292-4D64-8652-14069C9A6193

Q35125031-492B3ED3-8620-4785-B106-7600315FF255

Q35125031-84FB33B3-F392-416D-8FC2-FF1B47A8825E

Q35125031-AE046233-8E6C-435A-9265-520E1E8AD3C4

Q35125031-E940E71E-DD57-4B18-BC63-2EB85FBD3934

P932

Q35125031-6FA25ADF-BFB9-40EB-819C-2233DAF2CA0B

P356

JOURNAL.PONE.0091818

P1433

P1476

Survival benefits of metformin ...... atic review and meta-analysis.

@en

P2093

Ang Cui

http://www.w3.org/2001/XMLSchema#string

Chen-Ying Liu

http://www.w3.org/2001/XMLSchema#string

Guang-Hui Wang

http://www.w3.org/2001/XMLSchema#string

Long Cui

http://www.w3.org/2001/XMLSchema#string

Yun Liu

http://www.w3.org/2001/XMLSchema#string

Zhi-Jiang Zhang

http://www.w3.org/2001/XMLSchema#string

Zhong-Lin Liang

http://www.w3.org/2001/XMLSchema#string

Zu-Bing Mei

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

Type 2 diabetes mellitus and the risk of colorectal cancer.

Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

P304

e91818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0091818

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260949929

http://www.w3.org/2001/XMLSchema#string

P698

24647047

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

type-2 diabetes

colorectal neoplasm

maturity-onset diabetes of the young

P932

3960145

http://www.w3.org/2001/XMLSchema#string